Beijing Di Tan Hospital, Capital Medical University /ID# 218496

Beijing 100015

0 studies enrolling now · 1 studies all time

What they study most

Hepatitis C Virus Infection

Studies at this site

• Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study — Completed